Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$191.51 - $216.16 $37.2 Million - $42 Million
194,250 Added 434.18%
238,989 $50.7 Million
Q2 2023

Aug 14, 2023

SELL
$187.64 - $206.25 $50.2 Million - $55.2 Million
-267,457 Reduced 85.67%
44,739 $8.61 Million
Q1 2023

May 12, 2023

BUY
$127.59 - $203.08 $32.1 Million - $51.1 Million
251,400 Added 413.51%
312,196 $63.2 Million
Q4 2022

Feb 14, 2023

BUY
$117.37 - $139.17 $3.65 Million - $4.33 Million
31,100 Added 104.73%
60,796 $7.81 Million
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $3.62 Million - $4.83 Million
26,795 Added 923.65%
29,696 $4.06 Million
Q2 2022

Aug 12, 2022

SELL
$108.81 - $179.33 $2.68 Million - $4.41 Million
-24,593 Reduced 89.45%
2,901 $513,000
Q1 2022

May 13, 2022

BUY
$119.61 - $157.85 $2.94 Million - $3.88 Million
24,600 Added 850.03%
27,494 $3.96 Million
Q4 2021

Feb 14, 2022

SELL
$142.57 - $190.86 $12.4 Million - $16.7 Million
-87,255 Reduced 96.79%
2,894 $447,000
Q3 2021

Nov 12, 2021

BUY
$142.45 - $169.82 $7.61 Million - $9.07 Million
53,400 Added 145.31%
90,149 $15.3 Million
Q2 2021

Aug 13, 2021

BUY
$135.08 - $161.1 $4.96 Million - $5.92 Million
36,749 New
36,749 $5.8 Million
Q1 2021

May 14, 2021

SELL
$137.51 - $190.8 $172,575 - $239,454
-1,255 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$164.63 - $211.93 $206,610 - $265,972
1,255 New
1,255 $220,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.